Li, Y.; Li, Y.; Chen, N.; Feng, L.; Gao, J.; Zeng, N.; He, Z.; Gong, Q.
Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ: Involvement of ROS/NF-κB/IRS1 Signaling Pathway. Antioxidants 2022, 11, 1705.
https://doi.org/10.3390/antiox11091705
AMA Style
Li Y, Li Y, Chen N, Feng L, Gao J, Zeng N, He Z, Gong Q.
Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ: Involvement of ROS/NF-κB/IRS1 Signaling Pathway. Antioxidants. 2022; 11(9):1705.
https://doi.org/10.3390/antiox11091705
Chicago/Turabian Style
Li, Yiqi, Yeli Li, Nana Chen, Linying Feng, Jianmei Gao, Nan Zeng, Zhixu He, and Qihai Gong.
2022. "Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ: Involvement of ROS/NF-κB/IRS1 Signaling Pathway" Antioxidants 11, no. 9: 1705.
https://doi.org/10.3390/antiox11091705
APA Style
Li, Y., Li, Y., Chen, N., Feng, L., Gao, J., Zeng, N., He, Z., & Gong, Q.
(2022). Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ: Involvement of ROS/NF-κB/IRS1 Signaling Pathway. Antioxidants, 11(9), 1705.
https://doi.org/10.3390/antiox11091705